1. Home
  2. NSP vs GPCR Comparison

NSP vs GPCR Comparison

Compare NSP & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$38.86

Market Cap

1.5B

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$68.84

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSP
GPCR
Founded
1986
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
1997
2023

Fundamental Metrics

Financial Performance
Metric
NSP
GPCR
Price
$38.86
$68.84
Analyst Decision
Hold
Strong Buy
Analyst Count
3
11
Target Price
$47.67
$97.90
AVG Volume (30 Days)
1.2M
2.4M
Earning Date
02-09-2026
11-06-2025
Dividend Yield
6.16%
N/A
EPS Growth
N/A
N/A
EPS
0.45
N/A
Revenue
$6,757,000,000.00
N/A
Revenue This Year
$4.71
N/A
Revenue Next Year
$6.40
N/A
P/E Ratio
$87.11
N/A
Revenue Growth
3.19
N/A
52 Week Low
$31.00
$13.22
52 Week High
$95.98
$94.90

Technical Indicators

Market Signals
Indicator
NSP
GPCR
Relative Strength Index (RSI) 55.59 67.64
Support Level $37.99 $66.58
Resistance Level $39.50 $72.00
Average True Range (ATR) 1.17 3.84
MACD 0.20 -0.34
Stochastic Oscillator 69.25 75.13

Price Performance

Historical Comparison
NSP
GPCR

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: